Clinical trials
Phase 2 Squamous Cell Carcinoma of Head and Neck trials in Spain
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
40 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2005 | 1 |
| 2006 | 1 |
| 2013 | 1 |
| 2014 | 2 |
| 2015 | 2 |
| 2017 | 2 |
| 2018 | 3 |
| 2019 | 2 |
| 2020 | 3 |
| 2021 | 10 |
| 2022 | 3 |
| 2023 | 5 |
| 2024 | 1 |
| 2025 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 19 |
| Active, not recruiting | 7 |
| Terminated | 7 |
| Recruiting | 3 |
| Unknown status | 3 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Merck Sharp & Dohme LLC | 3 |
| ALX Oncology Inc. | 2 |
| European Organisation for Research and Treatment of Cancer - EORTC | 2 |
| Gilead Sciences | 2 |
| GlaxoSmithKline | 2 |
| Grupo Español de Tratamiento de Tumores de Cabeza y Cuello | 2 |
| IO Biotech | 2 |
| ISA Pharmaceuticals | 2 |
| Kura Oncology, Inc. | 2 |
| MacroGenics | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Squamous Cell Carcinoma of Head and Neck | 40 |
| Head and Neck Neoplasms | 14 |
| Carcinoma, Non-Small-Cell Lung | 4 |
| Melanoma | 4 |
| Neoplasm Metastasis | 3 |
| Recurrence | 3 |
| Anus Neoplasms | 2 |
| Carcinoma, Hepatocellular | 2 |
| Carcinoma, Squamous Cell | 2 |
| Cholangiocarcinoma | 2 |
Trials
Showing 1 to 25 of 40. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.